Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1376-1382, July 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kizer, D. E.
Right arrow Articles by Shirley, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kizer, D. E.
Right arrow Articles by Shirley, B. C.

Studies on the Relationship between Increased Adenylic Acid Deaminase Activity and Changes in Nuclear RNA Metabolism in Rat Liver Caused by Thioacetamide

Donald E. Kizer, Boyd A. Howell, Joseph A. Clouse and B. C. Shirley

Biomedical Division, The Samuel Roberts Noble Foundation, Inc., Ardmore, Oklahoma

The purpose of this study was to determine whether increases in AMP1 deaminase activity caused by TA injections were mediated by RNA biosynthesis. Multiple TA injections (50 mg/kg body weight) resulted in 2- to 3-fold increases in AMP deaminase activity, but simultaneous injection of Act. D (120 µg/kg body weight) or 5-FU (30 mg/kg body weight) with TA caused no interference with this increase. AMP deaminase was activated in vitro with ATP; however, in the presence of ATP the enzyme activity of TA-injected animals was twice that of saline controls, and these increases still were not inhibited by Act. D or 5-FU. On the other hand, Act. D inhibited, but 5-FU enhanced, the increases in nucleoli diameters caused by TA injections. Neither 1 nor 4 injections of Act. D alone changed the concentration of NNN2 or "nucleolar" RNA, and incorporation of orotic acid-6-14C into these fractions was not altered. When Act. D was injected simultaneously with TA, it did not inhibit increases in "nucleolar" RNA content nor increases in the incorporation of labeled orotic acid into the NNN fraction. Single injections of Act. D at 650 µg/kg body weight, alone or with TA, inhibited incorporation of orotic acid-6-14C into both NNN and "nucleolar" RNA about 50%. This high level of Act. D was divided into 18 doses and injected at 4-hr intervals over a 3-day period to TA-treated rats. Increases in AMP deaminase activity were not inhibited, but incorporation of labeled orotic acid was inhibited.

1 The abbreviations used are: AMP, adenylic acid; TA, thioacetamide; Act. D, actinomycin D; 5-FU, 5-fluorouracil; ATP, adenosine triphosphate; 3'-Me-DAB, 3'-methyl-4-dimethylaminoazobenzene; and IMP, inosinic acid.

2 "NNN" (nonnucleolar nuclear) and "nucleolar" were terms used by Koulish and Kleinfeld (18) to designate cytologically distinct portions of nuclear RNA. Here, "NNN" indicates the phosphate buffer-soluble fraction, while "nucleolar" indicates the 1 M NaCl-insoluble fraction of the Allfrey and Mirsky (1) subfractionation procedure. We have previously discussed the relationship of our NNN fraction to "nonnucleolar" nuclear RNA, and cytologic limitations have been recognized (17).

Received 11/17/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.